HRT Financial’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-384,265
| Closed | -$67.6M | – | 3812 |
|
|
2025
Q4 | $67.6M | Buy |
384,265
+379,819
| +8,543% | +$62.1M | 0.21% | 59 |
|
|
2025
Q3 | $622K | Sell |
4,446
-33,830
| -88% | -$4.57M | ﹤0.01% | 1764 |
|
|
2025
Q2 | $4.81M | Sell |
38,276
-140,066
| -79% | -$17.5M | 0.02% | 550 |
|
|
2025
Q1 | $24.4M | Buy |
+178,342
| New | +$25.5M | 0.15% | 92 |
|
|
2024
Q4 | – | Sell |
-89,217
| Closed | -$17.3M | – | 2447 |
|
|
2024
Q3 | $17.3M | Buy |
+89,217
| New | +$18.7M | 0.09% | 149 |
|
|
2023
Q3 | – | Sell |
-3,896
| Closed | -$1.11M | – | 2413 |
|
|
2023
Q2 | $1.11M | Buy |
+3,896
| New | +$1.16M | 0.01% | 890 |
|
|
2023
Q1 | – | Sell |
-133,064
| Closed | -$36.8M | – | 2508 |
|
|
2022
Q4 | $36.8M | Buy |
133,064
+97,102
| +270% | +$27.4M | 0.52% | 21 |
|
|
2022
Q3 | $9.6M | Buy |
35,962
+33,545
| +1,388% | +$7.12M | 0.1% | 148 |
|
|
2022
Q2 | $492K | Sell |
2,417
-4,250
| -64% | -$869K | 0.01% | 1613 |
|
|
2022
Q1 | $1.4M | Buy |
6,667
+3,690
| +124% | +$802K | 0.01% | 821 |
|
|
2021
Q4 | $714K | Sell |
2,977
-2,531
| -46% | -$651K | ﹤0.01% | 1487 |
|
|
2021
Q3 | $1.56M | Sell |
5,508
-7,531
| -58% | -$2.47M | 0.01% | 898 |
|
|
2021
Q2 | $4.51M | Buy |
+13,039
| New | +$3.95M | 0.04% | 332 |
|
|
2021
Q1 | – | Sell |
-28,316
| Closed | -$6.93M | – | 2695 |
|
|
2020
Q4 | $6.93M | Buy |
+28,316
| New | +$7.3M | 0.14% | 118 |
|
|
2020
Q3 | – | Sell |
-127,380
| Closed | -$34.1M | – | 1898 |
|
|
2020
Q2 | $34.1M | Buy |
+127,380
| New | +$38.3M | 1.02% | 12 |
|
|
2020
Q1 | – | Sell |
-1,309
| Closed | -$388K | – | 795 |
|
|
2019
Q4 | $388K | Sell |
1,309
-33,929
| -96% | -$9.41M | 0.02% | 635 |
|
|
2019
Q3 | $8.2M | Sell |
35,238
-10,148
| -22% | -$2.36M | 0.39% | 36 |
|
|
2019
Q2 | $10.6M | Buy |
+45,386
| New | +$10.5M | 0.67% | 29 |
|
|
2015
Q4 | – | Sell |
-2,719
| Closed | -$793K | – | 67 |
|
|
2015
Q3 | $793K | Buy |
+2,719
| New | +$898K | 0.68% | 25 |
|
|
2015
Q2 | – | Sell |
-631
| Closed | -$266K | – | 164 |
|
|
2015
Q1 | $266K | Buy |
+631
| New | +$249K | 0.34% | 39 |
|
Other funds holding BIIB
HRT Financial's BIIB Position: Q1 2026 in Review
HRT Financial sold out of Biogen (BIIB) in Q1 2026, closing a stake of 384,265 shares — an estimated $67.6M sold.
HRT Financial first reported a position in BIIB in Q1 2015 and held it in 20 quarters. The position peaked at $67.6M in Q4 2025. 1,011 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- HRT Financial reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
- HRT Financial sold 384,265 Biogen shares in Q1 2026, an estimated $67.6M.
- HRT Financial first reported a position in Biogen in Q1 2015 and held it in 20 quarters.
- HRT Financial's Biogen position peaked at $67.6M in Q4 2025.
- 1,011 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.